Evidence map›Paper›PMID 32122905›Full record

ArticleCancer research2020

A New Assay to Measure Intestinal Crypt Survival after Irradiation: Challenges and Opportunities.

Ruth J Muschel, Ester M Hammond, Mark W Dewhirst

Open access · bronzeAbstract readComment
PubMed Publisher
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Acid Sphingomyelinase-Ceramide Induced Vascular Injury Determines Colorectal Cancer Stem Cell Fate.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2022
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ruth J MuschelOxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom. ruth.muschel@oncology.ox.ac.uk.
Ester M HammondOxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-2335-3146
Mark W DewhirstDepartment of Radiation Oncology, Duke University, Durham, North Carolina.ORCID 0000-0003-3459-6546
CRUK/MRC Oxford Institute for Radiation Oncology · GBDuke University · US

Funding

Cancer Research UK 11563Cancer Research UK 19276
6 · The paper itself

Abstract

Radiotherapy is a critical component of many current, curative cancer treatments, yet it is accompanied by unavoidable irradiation of normal tissues. Abdominal and pelvic radiation almost always results in some dose delivered to the bowel with deleterious effects to the small and large intestines. While the likelihood of enteritis is dose dependent, there is also considerable variation between patients in both the extent of symptoms of enteritis as well as their duration. In this article, Martin and colleagues hypothesized that the radiation sensitivity of intestinal organoids could predict the sensitivity of individual patients to enteritis and have taken the first steps to develop such an assay.

Indexed as

EnteritisOrganoidsHumansIntestinesRadiation ToleranceStem Cells

Identifiers

PMID32122905
OpenAlexW3009197288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.